White & Case advised pharmaceutical multinational Takeda in connection with two distinct operations. The first matter sees Takeda involved as the seller of a pharmaceutical products portfolio, currently licensed to Hikma Pharmaceuticals. As a
Tags :White & Case
Niederer Kraft Frey advised Georg Fischer (GF) on its agreement with United Grinding Group, a Swiss-based grinding technology company, to sell GF’s Machining Solutions Division. The transaction values the division between CHF 630 million and
Following the announcement of the acquisition of Vodafone Italia on 15 March 2024, Swisscom notified the transaction to the EU Commission, Directorate-General for Competition, under the Foreign Subsidies Regulation on 19 August 2024. On 23 September 2024, the EU Commission confirmed
International law firm White & Case has advised Georg Fischer on its €2.1 billion voluntary recommended public cash tender offer for all the issued and outstanding shares in Uponor. Georg Fischer, founded in 1802 and headquartered in
VISCHER has advised ADVANZ PHARMA, a specialty pharmaceutical company headquartered in London, on all Swiss legal aspects of its USD 450m acquisition of the ex-US business of Intercept Pharmaceuticals, spanning from due diligence to transactional
White & Case has advised private equity investor Nordic Capital on its investment in Bilthouse Group, a new umbrella combining financial services providers (Baufi24 Baufinanzierung, Hüttig & Rompf and Creditweb). The new company Bithouse
Asml Holding has agreed to sell a 100% stake in BG Medical Applications, SwissOptic and SwissOptic Co., to Jenoptik. BG Medical Applications is a supplier of high-precision, custom optical components for the medical technology sector based
Mercuria Energy Group Limited has agreed to acquire an undisclosed stake in N+P Group BV, the Netherlands-based industrial residues recycling specialist, for an undisclosed consideration. Post transaction, Jennissen Family will own majority stake in
White & Case in Moscow advised Moscow Exchange on the transaction. The team was led by partner Nikolay Feoktistov
Galderma today announced the closing of the sale of Bübchen to Dallmann’s Pharma GmbH, a company of Katjes International.
